In an era of economic nationalism, Lutnick’s job may turn out to be more important than Bessent’s.

A clinical-stage biotechnology company will advance a novel autologous chimeric antigen receptor T-cell therapy that targets ...

Boston Scientific initially developed the concept for the Bolt IVL system, which is engineered to fracture calcium using ...